EleVation carE: a Randomized Controlled Trial on the Prevention of Acute Mountain Sickness With Suxiao Jiuxin Pill

PHASE2/PHASE3Not yet recruitingINTERVENTIONAL
Enrollment

168

Participants

Timeline

Start Date

August 31, 2024

Primary Completion Date

September 30, 2024

Study Completion Date

September 30, 2025

Conditions
Acute Mountain Sickness
Interventions
DRUG

Suxiao Jiuxin Pill

Suxiao Jiuxin Pill is a traditional Chinese medicine compound composed of Ligusticum Wallichii and Borneo Camphorwood, and its clinical safety has been confirmed. Traditional Chinese medicine theory believes that Suxiao Jiuxin Pill has the effects of promoting qi and blood circulation, removing blood stasis and relieving pain, which may help alleviate symptoms of AMS.

DRUG

Placebo

Placebo is made of less than 10% of the amount of Suxiao Jiuxin Pill, with similar dosage, odor, and taste.

All Listed Sponsors
collaborator

Tibet Autonomous Region Hospital of Traditional Tibetan Medicine

UNKNOWN

lead

Peking University First Hospital

OTHER

NCT06531161 - EleVation carE: a Randomized Controlled Trial on the Prevention of Acute Mountain Sickness With Suxiao Jiuxin Pill | Biotech Hunter | Biotech Hunter